Gottlieb, the FDA and dumbing down medicine
No abstract available. Article truncated at 150 words. In the last few weeks several events have occurred that might impact drug approval in the US. President Donald Trump's pick for FDA commissioner, Dr. Scott Gottlieb. Gottlieb, like many of Trump’s picks for administration healthcare positio...
Main Author: | Robbins RA |
---|---|
Format: | Article |
Language: | English |
Published: |
Arizona Thoracic Society
2017-04-01
|
Series: | Southwest Journal of Pulmonary and Critical Care |
Subjects: | |
Online Access: | http://www.swjpcc.com/news/2017/4/14/gottlieb-the-fda-and-dumbing-down-medicine.html |
Similar Items
-
FDA commissioner Gottlieb resigns
by: Robbins RA
Published: (2019-03-01) -
Drugs, Devices, and the FDA: Part 1
by: Gail A. Van Norman, MD
Published: (2016-04-01) -
Duvelisib: A 2018 Novel FDA-Approved Small Molecule Inhibiting Phosphoinositide 3-Kinases
by: Daniel A. Rodrigues, et al.
Published: (2019-05-01) -
Chloroquine, a FDA-approved Drug, Prevents Zika Virus Infection and its Associated Congenital Microcephaly in Mice
by: Chunfeng Li, et al.
Published: (2017-10-01) -
FDA and EMA Approvals of New Breast Cancer Drugs—A Comparative Regulatory Analysis
by: Chandra P. Leo, et al.
Published: (2020-02-01)